1	Collagen-poly	Collagen-poly	B-NP	JJ	O	5	NMOD	0
2	glycolic	glycolic	I-NP	JJ	O	5	NMOD	0
3	acid	acid	I-NP	NN	O	5	NMOD	0
4	hybrid	hybrid	I-NP	NN	O	5	NMOD	0
5	matrix	matrix	I-NP	NN	O	11	SUB	0
6	with	with	B-PP	IN	O	5	NMOD	0
7	basic	basic	B-NP	JJ	B-protein	10	NMOD	0
8	fibroblast	fibroblast	I-NP	NN	I-protein	10	NMOD	0
9	growth	growth	I-NP	NN	I-protein	10	NMOD	0
10	factor	factor	I-NP	NN	I-protein	6	PMOD	0
11	accelerated	accelerate	B-VP	VBD	O	0	ROOT	17	accelerated
12	angiogenesis	angiogenesis	B-NP	NN	O	16	NMOD	3	angiogenesis
13	and	and	I-NP	CC	O	16	NMOD	0
14	granulation	granulation	I-NP	NN	O	16	NMOD	0
15	tissue	tissue	I-NP	NN	O	16	NMOD	0
16	formation	formation	I-NP	NN	O	11	OBJ	2	formation
17	in	in	B-PP	IN	O	16	NMOD	0
18	diabetic	diabetic	B-NP	JJ	O	19	NMOD	0
19	mice	mouse	I-NP	NNS	O	17	PMOD	0
20	.	.	O	.	O	11	P	0

1	Because	Because	B-SBAR	IN	O	0	ROOT	0
2	poor	poor	B-NP	JJ	O	5	NMOD	0
3	skin	skin	I-NP	NN	O	5	NMOD	0
4	wound	wound	I-NP	NN	O	5	NMOD	0
5	healing	healing	I-NP	NN	O	9	SUB	0
6	associated	associate	B-VP	VBN	O	5	NMOD	0
7	with	with	B-PP	IN	O	6	VMOD	0
8	diabetes	diabetes	B-NP	NN	O	7	PMOD	0
9	is	be	B-VP	VBZ	O	1	SBAR	0
10	thought	think	I-VP	VBN	O	9	VC	0
11	to	to	I-VP	TO	O	12	VMOD	0
12	be	be	I-VP	VB	O	10	VMOD	0
13	partly	partly	B-ADVP	RB	O	12	VMOD	0
14	a	a	B-NP	DT	O	15	NMOD	0
15	result	result	I-NP	NN	O	24	SUB	0
16	from	from	B-PP	IN	O	15	NMOD	0
17	impaired	impaired	B-NP	JJ	O	18	NMOD	18	impaired
18	angiogenesis	angiogenesis	I-NP	NN	O	20	NMOD	3	angiogenesis
19	,	,	O	,	O	20	P	0
20	treatments	treatment	B-NP	NNS	O	16	PMOD	0
21	that	that	B-NP	WDT	O	20	NMOD	0
22	improve	improve	B-VP	VBP	O	21	SBAR	17	improve
23	angiogenesis	angiogenesis	B-NP	NN	O	22	OBJ	3	angiogenesis
24	could	could	B-VP	MD	O	12	VMOD	0
25	have	have	I-VP	VB	O	24	VC	0
26	important	important	B-NP	JJ	O	27	AMOD	0
27	clinical	clinical	I-NP	JJ	O	28	NMOD	0
28	applications	application	I-NP	NNS	O	25	OBJ	0
29	.	.	O	.	O	1	P	0

1	We	We	B-NP	PRP	O	3	SUB	0
2	herein	herein	B-ADVP	RB	O	3	VMOD	0
3	report	report	B-VP	VBP	O	0	ROOT	0
4	the	the	B-NP	DT	O	5	NMOD	0
5	effects	effect	I-NP	NNS	O	16	NMOD	0
6	of	of	B-PP	IN	O	5	NMOD	0
7	novel	novel	B-NP	JJ	O	9	NMOD	0
8	developed	develop	I-NP	VBN	O	9	NMOD	0
9	material	material	I-NP	NN	O	6	PMOD	0
10	,	,	O	,	O	16	P	0
11	collagen-poly	collagen-poly	B-NP	JJ	O	16	NMOD	0
12	glycolic	glycolic	I-NP	JJ	O	16	NMOD	0
13	acid	acid	I-NP	NN	O	16	NMOD	0
14	fiber	fiber	I-NP	NN	O	16	NMOD	0
15	hybrid	hybrid	I-NP	NN	O	16	NMOD	0
16	matrix	matrix	I-NP	NN	O	3	OBJ	0
17	,	,	O	,	O	16	P	0
18	being	be	B-VP	VBG	O	16	NMOD	0
19	used	use	I-VP	VBN	O	18	VC	0
20	together	together	B-ADVP	RB	O	19	VMOD	0
21	with	with	B-PP	IN	O	19	VMOD	0
22	basic	basic	B-NP	JJ	B-protein	25	NMOD	0
23	fibroblast	fibroblast	I-NP	NN	I-protein	25	NMOD	0
24	growth	growth	I-NP	NN	I-protein	25	NMOD	0
25	factor	factor	I-NP	NN	I-protein	21	PMOD	0
26	to	to	B-VP	TO	O	27	VMOD	0
27	promote	promote	I-VP	VB	O	16	NMOD	0
28	wound	wound	B-NP	NN	O	29	NMOD	0
29	healing	healing	I-NP	NN	O	27	OBJ	0
30	of	of	B-PP	IN	O	29	NMOD	0
31	full-thickness	full-thickness	B-NP	JJ	O	33	NMOD	0
32	skin	skin	I-NP	NN	O	33	NMOD	0
33	defects	defect	I-NP	NNS	O	30	PMOD	0
34	on	on	B-PP	IN	O	33	NMOD	0
35	the	the	B-NP	DT	O	36	NMOD	0
36	back	back	I-NP	NN	O	34	PMOD	0
37	of	of	B-PP	IN	O	36	NMOD	0
38	type	type	B-NP	NN	B-protein	41	NMOD	0
39	2	2	I-NP	CD	I-protein	41	NMOD	0
40	diabetic	diabetic	I-NP	JJ	I-protein	41	NMOD	0
41	Lepr	Lepr	I-NP	NN	I-protein	45	NMOD	0
42	(	(	O	(	O	44	DEP	0
43	db	db	B-NP	NN	O	44	DEP	0
44	)	)	O	)	O	41	NMOD	0
45	mice	mouse	B-NP	NNS	O	37	PMOD	0
46	.	.	O	.	O	3	P	0

1	Our	Our	B-NP	PRP$	O	2	NMOD	0
2	data	datum	I-NP	NNS	O	3	SUB	0
3	indicates	indicate	B-VP	VBZ	O	0	ROOT	0
4	that	that	B-SBAR	IN	O	3	VMOD	0
5	this	this	B-NP	DT	O	7	NMOD	0
6	therapeutic	therapeutic	I-NP	JJ	O	7	NMOD	0
7	approach	approach	I-NP	NN	O	9	SUB	0
8	markedly	markedly	B-ADVP	RB	O	9	VMOD	0
9	promotes	promote	B-VP	VBZ	O	4	SBAR	17	promotes
10	angiogenesis	angiogenesis	B-NP	NN	O	14	NMOD	3	angiogenesis
11	and	and	I-NP	CC	O	14	NMOD	0
12	granulation	granulation	I-NP	NN	O	14	NMOD	0
13	tissue	tissue	I-NP	NN	O	14	NMOD	0
14	formation	formation	I-NP	NN	O	9	OBJ	2	formation
15	in	in	B-PP	IN	O	9	VMOD	0
16	comparison	comparison	B-NP	NN	O	15	PMOD	0
17	with	with	B-PP	IN	O	16	NMOD	0
18	other	other	B-NP	JJ	O	19	NMOD	0
19	conditions	condition	I-NP	NNS	O	17	PMOD	0
20	14	14	B-NP	CD	O	21	NMOD	0
21	days	day	I-NP	NNS	O	15	PMOD	0
22	after	after	B-PP	IN	O	21	NMOD	0
23	wounding	wound	B-VP	VBG	O	22	PMOD	0
24	.	.	O	.	O	3	P	0

